Tiber Creek Group, representing Jazz Pharmaceuticals, is a biopharmaceutical company. It lobbied Congress on Medicare and Medicaid issues, including how Medicare covers orphan drugs (medicines for rare diseases). Filings show about $200,000 spent across four reports through its in-house and affiliated firm Tiber Creek Health Strategies.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
mr JAMES BRYANT HALL ii
The latest disclosures for this client.
TIBER CREEK HEALTH STRATEGIES, INC.
Q2YTIBER CREEK HEALTH STRATEGIES, INC.
Q1YTIBER CREEK HEALTH STRATEGIES, INC.
The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
TIBER CREEK HEALTH STRATEGIES, INC.
TIBER CREEK HEALTH STRATEGIES, INC.
Q3YTIBER CREEK HEALTH STRATEGIES, INC.
Q2YTIBER CREEK HEALTH STRATEGIES, INC.
Q1